Amgen (AMGN) Revenue — Quarter Ended Jun 30, 2023
Revenue increased in the current quarter compared to the prior quarter. Revenue also rose compared to the same quarter one year earlier.
Key takeaway
Quarter ended Jun 30, 2023 · FY2023 Q2
Revenue increased in the current quarter compared to the prior quarter. Revenue also rose compared to the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$7B
Revenue reported for this quarter.
Quarter-over-quarter
+14.4%
Change from the immediately preceding quarter.
Year-over-year
+5.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$26.6B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2022 | $6.7B | -0.8% |
| Dec 31, 2022 | $6.8B | -0.1% |
| Mar 31, 2023 | $6.1B | -2.1% |
| Jun 30, 2023 | $7B | +5.9% |
Revenue performance
The reported revenue direction is upward for the quarter. The sequential improvement follows a decline in the immediately preceding quarter.
Quarterly comparison
Compared with the immediately preceding quarter, revenue increased. Compared with the same quarter one year earlier, revenue also increased.
What to watch
The filing context mentions macroeconomic challenges and pricing pressures, but no specific causal link to revenue is provided.